The fate of ischemic limbs in patients with Buerger’s disease based on our 30-year experience: does smoking have a definitive impact on the late loss of limbs?
Masayuki Sugimoto(Nagoya University), Kimihiro Komori(Saiseikai Yahata General Hospital), Hiroshi Banno(Fujisawa City Hospital), Hirofumi Morimae(Nagoya University), Akio Kodama(Asahikawa Medical University), Hiroshi Narita(Kyoto Women's University), Hiroki Miyachi(Nagoya University), Kiyohito Yamamoto(Osaka Medical and Pharmaceutical University)
Cited by 29
Related Papers
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
|European Journal of Vascular and Endovascular Surgery|2019|1.5k
Angiogenic Gene Therapy for Experimental Critical Limb Ischemia
|Circulation Research|2002|238
Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-<i>d</i>]pyrimidine Scaffold
|Journal of Medicinal Chemistry|2011|223
Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia
|Circulation Cardiovascular Interventions|2017|181